对糖尿病和严重精神障碍患者实施医生主导的药物评估:随机对照试验
Johan Frederik Mebus Meyer Christensen1,2, Signe Wegmann Düring2,3, Gesche Jürgens1,2,4
1Research Unit for Clinical Psychopharmacology, Mental Health Service West, Copenhagen University Hospital-Psychiatry West Region Zealand, Slagelse, Denmark.
British journal of clinical pharmacology
|April 27, 2025
概括
医生主导的药物审查减少了糖尿病精神病患者的多药性治疗,而没有恶化症状. 这种方法有助于减缓处方,改善这种脆弱人群的药物管理.
科学领域:
- 精神病学是一个精神病学.
- 临床药理学 临床药理学
- 内分泌学 在内分泌学.
背景情况:
- 严重的精神障碍和糖尿病往往导致多药,增加不良事件和药物相互作用的风险.
- 药物评价可以帮助短期降低处方,但它们对临床结果的影响尚不清楚.
- 在患有糖尿病的精神病室门诊患者中优化药物治疗对于管理并发症和降低催产素风险至关重要.
研究的目的:
- 通过跨学科对话评估由医生主导的药物审查在改变处方模式方面的有效性.
- 评估这项干预措施对糖尿病精神病室患者药理疗效和耐受性的影响.
- 为了确定抑郁症是否可以安全地实施,而不会对精神症状产生负面影响.
主要方法:
- 一项涉及52名患有糖尿病的精神病室门诊患者在内分泌学家-精神病学家诊所的研究.
- 干预组接受了在跨学科会议上讨论的药物评估,而对照组接受了标准护理.
- 数据收集包括心理测试,副作用查,临床访谈和在基线和6个月后的电子健康记录提取.
主要成果:
- 干预组的中位数减少了1种药物和1种可能不合适的处方.
- 对照组经历了2种药物和2种可能不合适的处方的中位数增加.
- 在干预组中,身体和精神药物使用量都下降了,在临床结果中没有观察到差异.
结论:
- 通过跨学科对话进行由医生主导的药物审查,可以成功地在患有糖尿病的精神病室门诊患者中实现抑郁症.
- 这种干预可以减少多药,而不会加剧精神病症状.
- 这些发现支持整合跨学科药物评价,以优化复杂患者群体的药物治疗.
相关概念视频
Drug Therapy
28
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
28
Psychosis: Goals of Pharmacotherapy
95
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
95
Mania and Antimanic Drugs: Overview
101
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
101
Diabetes: Management and Pharmacotherapy
204
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
204
Psychosis and Antipsychotic Drugs: Overview
152
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
152
Antidepressant Drugs: MAOIs and Other Agents
160
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
160


